Degrees Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Tafenoquine Gets Orphan Drug Status for Acute Babesiosis

Babesiosis is an infectious disease caused by microscopic parasites, Babesia, that infect red blood cells.

United statesTufts medical centerGeoff dowDrug administrationDegrees pharmaceuticalsOrphan drug

Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind

Enrollment in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis to Begin at Tufts Medical Center; First Study of Its Kind
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United statesTufts medical centerGeoff dowDegrees pharmaceuticalsDegrees pharmaceuticals incTufts medical center on

60 Degrees Pharmaceuticals Announces First Quarter 2024 Results

60 Degrees Pharmaceuticals Announces First Quarter 2024 Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesKristen landonPatrick gaynesSheilaa burkeDrug administrationUs department of defenseGlobenewswire incExchange commissionDegrees pharmaceuticalsKnight therapeutics incDegrees pharmaceuticals incQuarter endedDrug supply chain security actChief commercial officerSecurities litigation reform actAnnual report

60 Degrees Pharmaceuticals, Inc (NASDAQ:SXTP) Sees Significant Growth in Short Interest

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 130,700 shares, a growth of 95.1% from the March 31st total of 67,000 shares. Currently, 1.5% of the shares of the company […]

United statesTafenoquine arakodaDegrees pharmaceuticals dailyDegrees pharmaceuticals incDegrees pharmaceuticalsDegrees pharmaceuticals price performanceGet free reportPharmaceuticals pricePharmaceuticals daily60 degrees pharmaceuticalsNasdaq sxtp

60 Degrees Pharmaceuticals (SXTP) to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis

60 Degrees Pharmaceuticals (SXTP) to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCarolina state universityDegrees pharmaceuticalsWalter reed army institute of researchDrug administrationUnited states army medical materiel development activityDegrees pharmaceuticals incCanine babesiosis pilot studytheInstitutional animal careUse committeeNorth carolina state universityCanine babesiosiscanineWalter reed army instituteUnited states army medicalMateriel development